Study Evaluating the Clinical and Therapeutic Management of Rheumatoid Arthritis in Spain

Wyeth is now a wholly owned subsidiary of Pfizer360 enrolled

Overview

This is an epidemiological, multicenter, retrospective study to analyze the management of rheumatoid arthritis (RA) in usual clinical practice in Spain. Two groups of patients will be analyzed: individuals who have had RA for two years or less (the "early RA" group) and individuals who have had RA for more than 2 years and who currently meet the ACR criteria for RA (the "established RA" group).

Study Type

OBSERVATIONAL

Enrollment

360

Conditions

Rheumatoid Arthritis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: * Group 1: early RA : patients with disease lasting 2 years or less, considered by the investigator as an early RA * Group 2: established RA: patients with disease lasting more than 2 years who meet the ACR criteria for RA Exclusion criteria: * Patients with any rheumatic disease different from RA * Participation in any clinical trial or study in the last 12 months

Outcomes

Primary Outcomes

Therapeutic management of the RA (actual and 12 month follow-up) in a real-world setting. Descriptive analysis of sociodemographics and clinical variables for patients and sorted by group (early and established RA) for the last 12 months

Time frame: 12 months

Secondary Outcomes

Measurements of diagnostic and outcomes used in the common clinical practice. Degree of follow-up of the actual Spanish consensus on clinical and therapeutic management of patients with RA

Time frame: 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.